Publication date: September 2016
Source:Oral Oncology, Volume 60
Author(s): Matthew C. Ward, Shlomo A. Koyfman
Transoral Robotic Surgery (TORS) is a fascinating new technology allowing for excellent functional outcomes after resection of head and neck tumors that previously required morbid surgical approaches for access. With a new technology, however, come new questions as to optimal patient selection and its impact on adjuvant therapy considerations. Here we review the issues most pertinent to a radiation oncologist adapting to the use of TORS. Patient selection, indications for adjuvant radiotherapy, radiation dose and target volumes are discussed. Finally, ongoing clinical trials and future directions are considered.
from #ENT via xlomafota13 on Inoreader http://ift.tt/29RcEuo
via IFTTT
Πέμπτη 21 Ιουλίου 2016
Transoral robotic surgery: The radiation oncologist’s perspective
Αναρτήθηκε από
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182
στις
8:19 π.μ.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου